Physician
Seebruck, Christopher
Seebruck, Christopher was paid $442K by Medicaid between Nov 2020 and Dec 2024, across 10 billing codes. Its largest line is J0178, Injection, aflibercept, 1 mg — 47% of everything it billed.
33Billing provider infoSEEBRUCK, CHRISTOPHER
WEST MIFFLIN, PA 15122
WEST MIFFLIN, PA 15122
33aNPI1598999542assigned 05/05/2009
33bProvider typeOphthalmology Physician
28Total paid$442K
24GClaims7,709
24DCodes billed10
24AFirst – last monthNov 2020 – Dec 2024
Compared with peers
Next to other Ophthalmology Physician providers in Pennsylvania
Rank by total paid#22 of 288
Median peer was paid$7K
This provider vs. median64×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 151 | $25K | |
| 2021 | 1,460 | $246K | |
| 2022 | 1,721 | $42K | |
| 2023 | 2,419 | $62K | |
| 2024incomplete | 1,958 | $67K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 47% | 927 | 798 | $210K |
| 67028 | Intravitreal injection of a pharmacologic agent | 32% | 2,608 | 2,287 | $142K |
| 92134 | 9.7% | 2,075 | 2,030 | $43K | |
| 92235 | 4.0% | 532 | 513 | $18K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.8% | 476 | 469 | $13K |
| J2778 | Injection, ranibizumab, 0.1 mg | 1.8% | 202 | 180 | $8K |
| J9035 | Injection, bevacizumab, 10 mg | 1.5% | 678 | 582 | $7K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 171 | 171 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 12 | 12 | $171.60 |
| C9257 | Injection, bevacizumab, 0.25 mg | 0% | 28 | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.